Physician profile
Mark S Fitzgerald
NPI 1124199682
$235,105.95
in general payments reported to CMS, 2019-2025
10 companies · $95K in 2025
The $95K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,146 · 2020: $119 · 2021: $419 · 2022: $12K · 2023: $25K · 2024: $99K · 2025: $95K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $187K · Travel and Lodging: $28K · Food and Beverage: $5,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $186,550.00 |
| Travel and Lodging | $27,701.59 |
| Food and Beverage | $5,365.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $229,383.31 | 2020-2025 | Primary Shoulder, Mecta, Gmk Sphere |
| Arthrex, INC. | $4,088.71 | 2019-2023 | |
| International Life Sciences | $537.19 | 2023 | |
| Gemini Mountain Medical, LLC | $514.78 | 2019-2024 | |
| Smith+Nephew, INC. | $214.04 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Avanos Medical | $124.43 | 2021 | |
| Depuy Synthes Sales INC. | $93.76 | 2020 | |
| Medtronic, INC. | $61.07 | 2021-2022 | |
| Stryker Corporation | $51.67 | 2021-2025 | Aequalis Perform Reversed |
| Abanza INC. | $36.99 | 2025 | Washercap Mini Fixation System 4.5mm, Washercap Fixation System 10mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Fitzgerald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.